Rockefeller Capital Management L.P. Has $14.47 Million Stock Holdings in Huron Consulting Group Inc. (NASDAQ:HURN)

Rockefeller Capital Management L.P. grew its stake in Huron Consulting Group Inc. (NASDAQ:HURN - Free Report) by 12.8% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 116,446 shares of the business services provider's stock after acquiring an additional 13,219 shares during the period. Rockefeller Capital Management L.P. owned 0.66% of Huron Consulting Group worth $14,470,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds have also modified their holdings of the stock. TI Trust Inc. acquired a new stake in shares of Huron Consulting Group during the fourth quarter worth $12,197,000. Franklin Resources Inc. grew its holdings in shares of Huron Consulting Group by 20.5% during the third quarter. Franklin Resources Inc. now owns 395,788 shares of the business services provider's stock worth $42,306,000 after buying an additional 67,239 shares in the last quarter. Norges Bank acquired a new stake in Huron Consulting Group in the 4th quarter valued at approximately $7,427,000. Jennison Associates LLC lifted its stake in Huron Consulting Group by 4.8% in the 4th quarter. Jennison Associates LLC now owns 601,335 shares of the business services provider's stock valued at $74,722,000 after acquiring an additional 27,329 shares in the last quarter. Finally, Kennedy Capital Management LLC grew its stake in shares of Huron Consulting Group by 38.1% during the 4th quarter. Kennedy Capital Management LLC now owns 87,805 shares of the business services provider's stock worth $10,911,000 after acquiring an additional 24,217 shares in the last quarter. 93.90% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

Several equities research analysts have issued reports on the stock. Barrington Research reiterated an "outperform" rating and issued a $167.00 price target on shares of Huron Consulting Group in a research note on Thursday, March 27th. Truist Financial boosted their target price on shares of Huron Consulting Group from $165.00 to $180.00 and gave the stock a "buy" rating in a report on Tuesday, March 4th. Benchmark restated a "buy" rating and set a $165.00 price objective on shares of Huron Consulting Group in a research note on Wednesday, March 26th. William Blair reiterated an "outperform" rating on shares of Huron Consulting Group in a research note on Wednesday, March 26th. Finally, Wedbush boosted their price target on Huron Consulting Group from $150.00 to $165.00 and gave the stock an "outperform" rating in a research report on Wednesday, March 26th. Six equities research analysts have rated the stock with a buy rating, According to MarketBeat.com, Huron Consulting Group currently has a consensus rating of "Buy" and an average target price of $169.25.

Huron Consulting Group Stock Performance

HURN stock traded down $3.17 during mid-day trading on Monday, hitting $138.33. 46,613 shares of the company were exchanged, compared to its average volume of 196,610. Huron Consulting Group Inc. has a 1-year low of $84.26 and a 1-year high of $153.85. The business has a 50 day simple moving average of $141.24 and a 200-day simple moving average of $127.80. The company has a current ratio of 1.61, a quick ratio of 1.61 and a debt-to-equity ratio of 0.82. The stock has a market capitalization of $2.48 billion, a PE ratio of 30.07 and a beta of 0.37.

Huron Consulting Group (NASDAQ:HURN - Get Free Report) last posted its quarterly earnings data on Tuesday, February 25th. The business services provider reported $1.90 earnings per share for the quarter, topping the consensus estimate of $1.52 by $0.38. Huron Consulting Group had a return on equity of 21.51% and a net margin of 5.80%. The firm had revenue of $399.31 million for the quarter, compared to analysts' expectations of $380.62 million. On average, equities analysts forecast that Huron Consulting Group Inc. will post 6.1 earnings per share for the current year.

Insider Activity at Huron Consulting Group

In other Huron Consulting Group news, CEO C. Mark Hussey sold 27,672 shares of Huron Consulting Group stock in a transaction on Tuesday, March 4th. The stock was sold at an average price of $145.91, for a total value of $4,037,621.52. Following the completion of the transaction, the chief executive officer now directly owns 81,118 shares of the company's stock, valued at $11,835,927.38. The trade was a 25.44 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director H Eugene Lockhart sold 1,042 shares of the stock in a transaction on Monday, February 3rd. The stock was sold at an average price of $125.15, for a total value of $130,406.30. Following the sale, the director now directly owns 24,672 shares in the company, valued at approximately $3,087,700.80. This trade represents a 4.05 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 78,781 shares of company stock worth $11,484,452. Company insiders own 2.15% of the company's stock.

About Huron Consulting Group

Huron Consulting Group Inc, a professional services firm, provides consultancy services in the United States and internationally. It operates through three segments: Healthcare, Education, and Commercial. The Healthcare segment provides financial and operational performance improvement consulting services; digital offerings, spanning technology and analytic-related services; software products; organizational transformation services; revenue cycle managed and outsourcing services; financial and capital advisory consulting services; and strategy and innovation consulting services to national and regional health systems, academic and community health systems, federal health system, public, children's and critical access hospitals, physician practices and medical groups, payors, and long-term care or post-acute providers.